Biotechnology

FDA Grants Novartis Biologic Breakthrough Status

FDA Grants Novartis Biologic Breakthrough Status

By Dan Stanton

A third Novartis biopharmaceutical has received breakthrough designation status from the FDA allowing ‘fast-track’ development and review without compromising safety, the company says.

GE and iBio designing plant-cell based vaccine facility

GE and iBio designing plant-cell based vaccine facility

By Gareth Macdonald

GE Healthcare has started designing a vaccine manufacturing facility for an unnamed drug company, just days after expanding its collaboration with plant-cell production technology firm iBio.